LISATA THERAPEUTICS, INC. Deferred Tax Assets, Capital Loss Carryforwards
LISATA THERAPEUTICS, INC. (LSTA) had Deferred Tax Assets, Capital Loss Carryforwards of $0 as of 2017-12-31, per its 10-K filed 2018-03-22.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsCapitalLossCarryforwards · last filed 2018-03-22
- 2017-12-31: Deferred Tax Assets, Capital Loss Carryforwards $0.00.
- 2016-12-31: Deferred Tax Assets, Capital Loss Carryforwards $6.99M; Deferred Tax Assets, Capital Loss Carryforwards as first filed $6.99M.
- 2015-12-31: Deferred Tax Assets, Capital Loss Carryforwards $6.97M.
- 2014-12-31: Deferred Tax Assets, Capital Loss Carryforwards $6.93M.
| Period end | Deferred Tax Assets, Capital Loss Carryforwards | Deferred Tax Assets, Capital Loss Carryforwards as first filed |
|---|---|---|
| 2017-12-31 | $0.00 10-K · filed 2018-03-22 | |
| 2016-12-31 | $6.99M 10-K · filed 2018-03-22 | $6.99M 10-K · filed 2017-03-17 |
| 2015-12-31 | $6.97M 10-K · filed 2017-03-17 | |
| 2014-12-31 | $6.93M 10-K · filed 2016-03-15 | |
| 2013-12-31 | $6.64M 10-K · filed 2016-03-15 | $7.04M 10-K · filed 2014-03-13 |
| 2012-12-31 | $6.64M 10-K · filed 2015-03-02 | |
| 2011-12-31 | $0.00 10-K · filed 2013-03-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| BIOVIE INC. (BIVI) | United States | $0.012B |